News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Patent Expiry May Open $90 Billion Drug Market for Dr. Reddy's Laboratories Ltd. (RDY)


6/23/2010 7:06:06 AM

Bloomberg -- Dr. Reddy’s Laboratories Ltd. may be the biggest beneficiary among Indian generic-drug makers as $157 billion of medicines including Eli Lilly & Co.’s Zyprexa lose patent protection within five years, HDFC Securities Ltd. said.

Read at Business Week

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES